MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates
Open Access
- 31 January 2010
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 138 (1) , 159-164
- https://doi.org/10.1053/j.gastro.2009.09.053
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 DA016065, U01 A1052748)
This publication has 19 references indexed in Scilit:
- Highly active antiretroviral therapy improves ESLD‐free survival in HIV‐HCV co‐infectionHaemophilia, 2009
- Viral hepatitis and HIV coinfectionJournal of Hepatology, 2008
- Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter studyJournal of Hepatology, 2007
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- Viral Hepatitis in HIV InfectionNew England Journal of Medicine, 2007
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United StatesJournal of Viral Hepatitis, 2006
- Liver-Related Deaths in Persons Infected With the Human Immunodeficiency VirusArchives of internal medicine (1960), 2006
- Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?AIDS, 2005
- Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver diseaseLiver Transplantation, 2005